Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $75.93 USD
Change Today +0.47 / 0.62%
Volume 337.8K
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

fei company (FEIC) Key Developments

FEI Company Reports Unaudited Consolidated Results for the First Quarter Ended March 29, 2015; Provides Earnings Guidance for the Second Quarter and Full Year of 2015

FEI Company reported unaudited consolidated results for the first quarter ended March 29, 2015. First quarter revenue of $221 million was down 2.4% compared to $226 million for first quarter of 2014. Diluted earnings per share were $0.66 for the first quarter of 2015, compared with $0.59 for the first quarter of 2014. Net income for the quarter was $28 million compared with $25 million for the first quarter of 2014. Operating income was $36.2 million against $30.9 million and income before taxes was $35.3 million against $30.6 million reported last year. Net cash provided by operating activities for the first quarter of 2015 was $23 million against $28.4 million reported last year. Acquisition of property, plant and equipment was $5.2 million against $4.3 million reported last year. For the second quarter of 2015, the company currently expects reported revenue to be in the range of $216 million to $226 million. This range includes a negative impact related to the stronger U.S. dollar of approximately 6% on reported revenue as compared to the second quarter of 2014. Earnings per fully diluted share are expected to be in the range of $0.73 to $0.83. The effective tax rate for the second quarter is expected to be approximately 20%. The company expects gross margins in the quarter will be above 49%. For full year 2015, the company currently expects organic revenue growth to be in the range of 4% to 7% compared with 2014. Based on current exchange rates, the stronger U.S. dollar is expected to negatively impact full year 2015 reported revenue growth by approximately 5% as compared to the full year 2014. Earnings per fully diluted share are currently expected to be in the range of $3.40 to $3.70. The effective tax rate for the full year is expected to be approximately 20%.

FEI Company Announces Resignation of Benjamin Loh as Executive Vice President and Chief Operating Officer

On April 14, 2015, Benjamin Loh, Executive Vice President and Chief Operating Officer of FEI Company notified the Company of his decision to resign, effective immediately. The resignation was a personal decision, and Mr. Loh's departure does not reflect any material changes to the Company's business, operations or financial results.

FEI Company to Report Q1, 2015 Results on Apr 28, 2015

FEI Company announced that they will report Q1, 2015 results at 2:00 PM, Pacific Standard Time on Apr 28, 2015

FEI Company, Q1 2015 Earnings Call, Apr 28, 2015

FEI Company, Q1 2015 Earnings Call, Apr 28, 2015

FEI Company Completes the Installation of a New Talos Arctica Cryo-Transmission Electron Microscope

FEI Company has completed the installation of a new Talos Arctica cryo-transmission electron microscope (TEM) at the Okinawa Institute of Science and Technology Graduate University in Japan. Scientists will use the new Talos Arctica for high-resolution, three-dimensional (3D) analysis of biological molecules or macro-molecular complexes in their native, fully-hydrated state. The Talos Arctica cryo-TEM incorporates sophisticated automation and electron optical technologies, pioneered on FEI's Titan Krios TEM, but provides a lower cost of entry for structural biologists who want to increase analytical productivity and reduce time-to-answer. The Talos Arctica is a powerful, stable, and highly automated cryo-TEM that is optimized for high-resolution 3D imaging of proteins and macromolecular assemblies and high-resolution cellular tomography. Its high throughput, stability and ease-of-use enable scientists to quickly obtain better insight and understanding of macromolecular structures, cellular components, cells and tissues in three dimensions. Its stability and revolutionary cryo capabilities support a full range of applications including: SPA, electron crystallography and cryo-electron tomography.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FEIC:US $75.93 USD +0.47

FEIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bruker Corp $19.54 USD +0.57
Cognex Corp $45.93 USD +1.04
Entegris Inc $13.41 USD +0.10
II-VI Inc $17.88 USD +0.09
MKS Instruments Inc $35.67 USD +0.86
View Industry Companies
 

Industry Analysis

FEIC

Industry Average

Valuation FEIC Industry Range
Price/Earnings 29.8x
Price/Sales 3.3x
Price/Book 3.2x
Price/Cash Flow 29.3x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FEI COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.